The largest database of trusted experimental protocols

5 protocols using ishikawa cell line

1

Endometrial Adenocarcinoma Tissue Microarray

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endometrial adenocarcinoma samples from 70 patients were assembled into tissue microarrays. These patients had received neither prior medical treatment nor radiotherapy for cancer. The normal endometrial, simple hyperplasia endometrial, complex hyperplasia endometrial, and atypical hyperplasia endometrial samples were from 22, 23, 21, and 26 patients, respectively. These samples were prepared from paraffin blocks obtained from the Pathology Department at the Beijing Chao-Yang Hospital of Capital Medical University. The patients' clinicopathological data were retrospectively achieved from the Department of Obstetrics and Gynecology of Beijing Chao-Yang Hospital. The endometrial adenocarcinoma cell line was the Ishikawa cell line purchased from the American Type Culture Collection (Manassas, VA, USA).
+ Open protocol
+ Expand
2

Establishment and Characterization of Endometrial Adenocarcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human endometrial adenocarcinoma cell line, the Ishikawa cell line [92 (link)], was obtained from American Type Culture Collection (ATCC) (Manassas, VA) [93 (link)]. The primary tumor-derived endometrial adenocarcinoma cell lines originated from patients with Stage IC Grade 3 (ACI-181), Stage IIB Grade 2 (ACI-52), and Stage IIIC Grade 2 (ACI-80) International Federation of Gynecology and Obstetrics (FIGO) staging (gift from Dr. Risinger, Michigan State University, Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids 49503, MI, USA) (Supplementary Table 1). All cell lines used in this study are identified as having endometrioid histologic characteristics and were grown-maintained as previously described [74 (link), 75 (link)]. In brief, cells were grown in phenol red free-DMEM (Cellgro-Mediatech, Inc., Manassas, VA, USA) supplemented with 10% FBS (Atlanta Biologicals, Lawrenceville, GA, USA) and 2 mM L-Glutamine (Quality Biological Inc., Gaithersburg, MD, USA). These cells were maintained at 37°C with humidified atmosphere of 5% CO2 until 90–100% confluence was reached. Cells were subsequently passaged in a 1:5 ratio into 10-cm dishes (Costar, Corning, NY, USA).
+ Open protocol
+ Expand
3

Cell Culture Protocol for EMT Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS-isolated EPCAM+ and EPCAM cells were cultured in Modified Eagle Medium (Capricorn Scientific, SP-2002-500 ml) supplemented with 10% fetal bovine serum (FBS) (Serana, S-FBS-SA-015), 4 μg ml-1 hydrocortisone (Sigma, H0888) 1% penicillin/streptomycin (100×) (Capricorn Scientific, PS-B), 2 mM l-glutamine, 2 ml amphotericin B (100×) (Capricorn Scientific, AMP-B) and 500 μl T3 (Sigma, T6397). Cells were washed with Dulbecco’s phosphate buffered saline (PBS 1×) and detached from the cell culture plate with trypsin (Capricorn Scientific, TRY-2B10).
The A549 cell line was donated by R. Derynck and has been used in vitro as model in which EMT is plastic and can be induced by TGFβ19 (link). These cells were cultured in DMEM (Gibco, 11965092) with 10% FBS and 1% penicillin/streptavidin. For EMT induction, cells were plated, deprived in FBS the following day for 24 h, then treated with recombi nant TGFβ1 (Peprotech, 100-21) at 5 μg ml-1 in vitro for 3 days or 6 days (treatment every 2 days) in DMEM 1.5% FBS.
The Ishikawa cell line, a well-differentiated endometrial adenocarcinoma cell line with netrin-1 and UNC5B expression, was purchased from the American Type Culture Collection (ATCC).
They were grown in Minimum Essential Medium (Ozyme, COR10-009-CV), supplemented with 1% of penicillin/streptomycin and 5% FBS at 37 °C with saturating humidity and 5% CO2.
+ Open protocol
+ Expand
4

CRKL Overexpression in Ishikawa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Ishikawa cell line was obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle medium (Invitrogen; Thermo Fisher Scientific, Inc.) containing 10% fetal calf serum (Invitrogen; Thermo Fisher Scientific, Inc.), 100 IU/ml penicillin (Sigma-Aldrich) and 100 µg/ml streptomycin (Sigma-Aldrich) at 37°C in an atmosphere of 5% CO2. Cells were grown on sterilized culture dishes and were passaged every 2 days with 0.25% trypsin (Invitrogen; Thermo Fisher Scientific, Inc.).
The pCMV6-CRKL plasmid was purchased from OriGene Technologies, Inc. (Rockville, MD, USA), and was transfected into the cells using Lipofectamine 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.). The pCMV6 empty vector was used as a negative control. Cells were harvested 48 h after transfection and subjected to various analyses.
+ Open protocol
+ Expand
5

Endometrial Stromal Cell Isolation and Ishikawa Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endometrial tissues were cut into 2–3 mm pieces and digested with 1 mg/mL of collagenase type 1A in DMEM/F12 for 1.5 h at 37°C. It was then filtered through 250 µm nylon sieve to remove mucus and undigested tissue. The filter was passed through a 40 µm nylon sieve, which allowed the stromal cells to pass through, while intact glands were retained. Glands were recovered from the filter by backwashing with DMEM/F12 containing 10% bovine serum albumin and seeded on to the six-well plates for future study for certain durations.
The Ishikawa cell line (American Type Culture Collection, Manassas, VA, USA) was obtained from Shanghai Institutes for Biological Science and maintained in RPMI-1640 medium (Gibco; Thermo Fisher Scientific) containing 10% fetal bovine serum (FBS) and 100 U/mL penicillin and streptomycin antibiotics. When the cells reached confluence, the medium was replaced with phenol red free RPMI-1640 supplemented with 10% charcoal/dextran-treated FBS (all purchased from Sigma-Aldrich). For hormonal treatments, E2 (Sigma-Aldrich) was added to the culture media to a final concentration of 10−9 M (close to the physiological concentration in women at the mid-secretory phase) and 10−7 M (close to the supraphysiological concentration in women with controlled ovarian hyperstimulation), for certain durations according to the experimental purposes (Valbuena et al. 2001 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!